Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study

Published:2021-07 Issue: Volume:96 Page:107755
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Aryanian Zeinab,Balighi Kamran,Daneshpazhooh Maryam,Karamshahi Emad,Hatami Parvaneh,Goodarzi Azadeh,Tajalli Mahroo,Vance Terrence M.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference23 articles.

1. Influence of treatment on the clinical course of pemphigus vulgaris;Carson;J. Am. Acad. Dermatol.,1996

2. Mechanisms involved in the side effects of glucocorticoids;Scha¨cke;Pharmacol. Ther.,2002

3. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature;Cianchini;Arch. Dermatol.,2007

4. A single cycle of rituximab for the treatment of severe pemphigus;Joly;N. Engl. J. Med.,2007

5. Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients;Lunardon;Arch. Dermatol.,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis;Journal of Autoimmunity;2024-12

2. A Comprehensive Review on the Efficacy of Anti-CD20 Therapies in Pemphigus Treatment;Cureus;2024-04-23

3. Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?;Journal of Cosmetic Dermatology;2023-11-02

4. Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases;Clinical Case Reports;2023-11

5. Steroid as a Saviour and Culprit in Pemphigus Vulgaris Therapy: A Rare Case Series;Current Drug Therapy;2023-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3